- Understanding where patient concerns lie when participating in clinical trials and what pharma companies can do to mitigate against these
- Aiming to reduce the burden of trial participation on patients as much as possible: where are pharma companies falling short?
- What more needs to be done when it comes to patient accessibility for clinical trials?
